Answers are grounded in this paper and cite their sources.
Optimal salvage therapy for refractory HLH is unknown.In our patient, ruxolitinib treatment led to clinical remission of refractory HLH.
No takes yet. Share an insight, caveat, or question.
Broglie et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: